Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients

Overview of attention for article published in Molecular Diagnosis & Therapy, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 6 patents

Readers on

mendeley: 29 Mendeley

Summary Patents

So far, Altmetric has seen 6 patents that reference this research output.

Stable multi-dose compositions comprising an antibody and a preservative

Grant US-10835602-B2

United States of America

Stable antibody containing compositions

Grant US-10709782-B2

United States of America

Biological markers and methods for predicting response to B-cell antagonists

Grant US-9982302-B2

United States of America

Methods for treating, diagnosing, and monitoring rheumatoid arthritis

Grant US-9822400-B2

United States of America

Stable antibody containing compositions

Grant US-9795674-B2

United States of America

Methods for treating, diagnosing, and monitoring rheumatoid arthritis

Grant US-8728730-B2

United States of America